---
title: "Montega reiterates Buy on AlzChem, sets EUR 220 price target"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294387210.md"
description: "Montega reiterated a Buy rating on AlzChem with a EUR 220 price target. AlzChem reported Q2 revenue of EUR 155.3 million, up 8.7% YoY and beating estimates, while EBITDA rose 10.7% to EUR 32.2 million. The company maintained its full-year guidance at approximately EUR 600 million in revenue and EUR 126 million in EBITDA. Additionally, Montega highlighted progress in capacity expansion, including a nitroguanidine ramp-up in Germany starting in the second half."
datetime: "2026-07-30T15:18:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294387210.md)
  - [en](https://longbridge.com/en/news/294387210.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294387210.md)
generator: "portal-rs"
---

# Montega reiterates Buy on AlzChem, sets EUR 220 price target

-   Montega reiterated a Buy rating on AlzChem, keeping its 12-month price target at EUR 220. \* Q2 revenue rose 8.7% year over year to EUR 155.3 million, beating Montega’s EUR 147 million estimate. \* Q2 EBITDA increased 10.7% to EUR 32.2 million, despite pressure in Basics & Intermediates. \* Guidance stayed unchanged at about EUR 600 million revenue, about EUR 126 million EBITDA. \* Montega flagged capacity expansion progress, including a nitroguanidine ramp-up in Germany starting in H2. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AlzChem Group AG published the original content used to generate this news brief via EQS News (Ref. ID: rc\_26340) on July 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [ACT.DE](https://longbridge.com/en/quote/ACT.DE.md)
- [EQS.DE](https://longbridge.com/en/quote/EQS.DE.md)

## Related News & Research

- [Montega raises AlzChem price target to EUR 220, keeps buy rating](https://longbridge.com/en/news/292297962.md)
- [AlzChem picks South Carolina site for US nitroguanidine plant under US government contract, plans USD 150 million investment](https://longbridge.com/en/news/292032089.md)
- [BASF outlines at least €12 billion 2025-28 shareholder payouts under Winning Ways strategy](https://longbridge.com/en/news/298418301.md)
- [Seco expects 2027 revenue at EUR 270 million, cites Neura Robotics partnership boost](https://longbridge.com/en/news/298566998.md)
- [Should You Investigate Oxford Nanopore Technologies plc (LON:ONT) At UK£1.61?](https://longbridge.com/en/news/298103630.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**